Arrowhead says its RNAi drug crossed the blood-brain barrier in healthy volunteers and sharply lowered tau, a protein tied to Alzheimer’s.

GlobalData says more adults with type 2 diabetes in England hit blood sugar and weight targets on tirzepatide than on ...

A new review argues postpartum recovery may shape lifelong aging; a fandom health standard asks who helps mothers get there.

INmune Bio is pairing a quantum machine with AI to find diseases beyond Alzheimer’s that its drug candidate might help.

Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.

KAUST and Oxford researchers used a transistor-based sensor to read three forms of alpha-synuclein, reaching 90.9% accuracy ...

TimePie's Hebe Chen spotlights key developments from Shanghai, from therapeutic targets to China’s expanding clinical ...

Cognition Therapeutics wins a US patent on a new crystal form of zervimesine and has an FDA meeting on its Lewy body trial ...

Immorta Bio says its AI-designed SenoMune-0257 prompts T cells to clear senescent cells, and plans first human evaluation ...

A two-year partnership with Ultrahuman aims to connect clinical biomarkers and wearable data, bringing aging assessment into ...

Shmouni and Koehl Robinson unpack peptide medicine, from GLP-1s and BPC-157 to evidence, safety, regulation and personalized ...

As pharma shops for de-risked science, venture money is moving later and concentrating in fewer, bigger bets – our report ...